NYSE:DHR Danaher (DHR) Stock Price, News & Analysis $220.42 -7.14 (-3.14%) Closing price 03:59 PM EasternExtended Trading$223.53 +3.11 (+1.41%) As of 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Danaher Stock (NYSE:DHR) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Danaher alerts:Sign Up Key Stats Today's Range$219.92▼$228.1750-Day Range$203.44▼$236.7752-Week Range$160.93▼$242.80Volume3.99 million shsAverage Volume4.41 million shsMarket Capitalization$155.07 billionP/E Ratio36.08Dividend Yield0.73%Price Target$242.91Consensus RatingModerate Buy Company Overview Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy. Danaher serves customers in healthcare, pharmaceutical and biotechnology, academic, and research markets around the world. Founded in 1969 and headquartered in Washington, D.C., Danaher has grown through acquisitions and portfolio changes. It applies its Danaher Business System, a set of management and continuous-improvement practices, across its operating companies. Rainer M. Blair has served as the company’s president and chief executive officer since 2020.AI Generated. May Contain Errors. Read More Danaher Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks71st Percentile Overall ScoreDHR MarketRank™: 3.56179466006 of 5 starsDanaher scored higher than 71% of companies evaluated by MarketBeat, and ranked 179th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingModerate Buy Consensus RatingDanaher has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on no strong buy ratings, 18 buy ratings, 5 hold ratings, and no sell ratings.Upside PotentialDanaher has a consensus price target of $242.91, representing about 10.2% upside from its current price of $220.42.Amount of Analyst CoverageDanaher has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Danaher's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth8.27% Earnings GrowthEarnings for Danaher are expected to grow by 8.27% in the coming year, from $8.59 to $9.30 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Danaher is 36.08, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.30.Price to Earnings Ratio vs. SectorThe P/E ratio of Danaher is 36.08, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.47.Price to Earnings Growth RatioDanaher has a PEG Ratio of 2.87. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDanaher has a P/B Ratio of 2.89. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Danaher's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.34% of the float of Danaher has been sold short.Short Interest Ratio / Days to CoverDanaher has a short interest ratio ("days to cover") of 1.76, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Danaher has recently increased by 2.94%, indicating that investor sentiment is decreasing. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldDanaher has a dividend yield of 0.70%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthDanaher has only been increasing its dividend for 2 years.Dividend CoverageThe dividend payout ratio of Danaher is 26.19%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Danaher will have a dividend payout ratio of 17.20% next year. This indicates that Danaher will be able to sustain or increase its dividend.Read more about Danaher's dividend. News and Social Media3.2 / 5News Sentiment1.17 News SentimentDanaher has a news sentiment score of 1.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.42 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Danaher this week, compared to 7 articles on an average week.Search InterestOnly 14 people have searched for DHR on MarketBeat in the last 30 days. This is a decrease of -13% compared to the previous 30 days.MarketBeat FollowsOnly 7 people have added Danaher to their MarketBeat watchlist in the last 30 days. This is a decrease of -22% compared to the previous 30 days. Company Ownership1.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Danaher insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,266,489.00 in company stock.Percentage Held by Insiders10.80% of the stock of Danaher is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions79.05% of the stock of Danaher is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Danaher's insider trading history. Receive DHR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Danaher and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DHR Stock News HeadlinesDanaher Partners With Microsoft For AI-powered Ecosystem Involving Scientific InstrumentsNovember 20 at 1:12 PM | rttnews.comDanaher, Microsoft to collaborate on development of smart scientific instrumentsNovember 20 at 1:12 PM | tipranks.comELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th. A free Masterclass claims to reveal what Musk filed with regulators and why he's working to keep it quiet.November 20 at 1:00 AM | Paradigm Press (Ad)Stanley Druckenmiller, Dan Loeb and 12 Other Big Funds Sold Danaher Last Quarter, While 26 Bought. Who’s Right?November 20 at 1:12 PM | finance.yahoo.comDanaher Corporation (DHR) Raised Its Earnings Guidance as Core Growth Recovered: Is the Turnaround Gaining Momentum?November 20 at 1:11 PM | insidermonkey.comDanaher Collaborates with Microsoft to Make Scientific Instruments Agentically Connected and Laboratories More IntelligentNovember 20 at 7:30 AM | prnewswire.comDanaher Corporation (DHR) Presents at Jefferies Global Healthcare Conference 2026 TranscriptNovember 17 at 12:48 PM | seekingalpha.comDanaher (NYSE:DHR) Stock: Insider Gregory Milosevich Sells 2,100 SharesNovember 11, 2026 | insidertrades.comSee More Headlines DHR Stock Analysis - Frequently Asked Questions How have DHR shares performed this year? Danaher's stock was trading at $228.99 at the beginning of the year. Since then, DHR shares have decreased by 3.7% and is now trading at $220.4190. How were Danaher's earnings last quarter? Danaher Corporation (NYSE:DHR) posted its earnings results on Wednesday, October, 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.92 by $0.19. The company's revenue was up 8.3% on a year-over-year basis. Read the conference call transcript. Does Danaher have any subsidiaries? Danaher subsidiaries include these companies: Aldevron, Precision NanoSystems, Aquatic Informatics, Cytiva, GE Biopharma, Integrated DNA Technologies, IDBS Group, and others. Who are Danaher's major shareholders? Top institutional investors of Danaher include State Street Corp (4.06%), Dodge & Cox (1.43%), Fisher Asset Management LLC (0.65%) and Assenagon Asset Management S.A. (0.30%). Insiders that own company stock include Steven M Rales, Steven M Rales, Alan G Spoon, Rainer Blair, Joakim Weidemanis, Linda Filler, Daniel Raskas, Matthew Mcgrew, Gregory M Milosevich, Teri List, Christopher Paul Riley, Brian W Ellis, Walter G Lohr, Christopher Bouda and Georgeann Couchara. View institutional ownership trends. How do I buy shares of Danaher? Shares of DHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Danaher own? Based on aggregate information from My MarketBeat watchlists, some other companies that Danaher investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Salesforce (CRM), Visa (V), Walt Disney (DIS), Costco Wholesale (COST) and Home Depot (HD). Company Calendar Record date for 10/30 Dividend9/30/2026Ex-Dividend for 10/30 Dividend9/30/2026Last Earnings10/21/2026Dividend Payable10/30/2026Today11/20/2026Fiscal Year End12/31/2026Next Earnings (Estimated)1/27/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 DHR's financial health is in the Green zone, according to TradeSmith. DHR has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNYSE:DHR CIK313616 Webwww.danaher.com Phone(202) 828-0850Fax202-828-0860Employees60,000Year Founded1984Price Target and Rating Average Price Target for Danaher$242.91 High Price Target$275.00 Low Price Target$195.00 Potential Upside/Downside+10.2%Consensus RatingModerate Buy Rating Score (0-4)2.78 Research Coverage23 Analysts Profitability EPS (Trailing Twelve Months)$6.11 Trailing P/E Ratio36.08 Forward P/E Ratio23.70 P/E Growth2.87Net Income$3.61 billion Net Margins16.91% Pretax Margin18.81% Return on Equity11.17% Return on Assets6.71% Debt Debt-to-Equity Ratio0.45 Current Ratio1.63 Quick Ratio1.29 Sales & Book Value Annual Sales$24.57 billion Price / Sales6.31 Cash Flow$10.97 per share Price / Cash Flow20.10 Book Value$76.23 per share Price / Book2.89Miscellaneous Outstanding Shares703,530,000Free Float627,550,000Market Cap$155.07 billion OptionableOptionable Beta0.76 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSE:DHR) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | Sponsored6 Men Secretly Changed America’s Money. Now It’s Happening AgainIn 1910, six powerful men secretly met to lay the groundwork for the Federal Reserve, reshaping America's fina...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Danaher Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Danaher With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.